Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Reduces Preferred Stock Conversion Price, Capitalizes Unpaid Cash as Unsecured Debt

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$0.088
Mkt Cap
$2.63M
52W Low
$0.083
52W High
$8
Market data snapshot near publication time

summarizeSummary

Functional Brands Inc. reduced the conversion price for its Series C Preferred Stock and converted unpaid cash obligations into unsecured debt, indicating financial strain and increased dilution risk for common shareholders.


check_boxKey Events

  • Preferred Stock Conversion Price Reduced

    The conversion price for Series C Convertible Preferred Stock was lowered to $0.1636 per share, replacing previous tiered prices. This price was the market price on May 11, 2026, but is now above the current market price of $0.0883.

  • Below-Price Conversion Prohibition Waived

    The company waived the prohibition on converting preferred stock below the market price, allowing holders to convert at $0.1636 even if the common stock trades lower, increasing the likelihood of dilution for common shareholders.

  • Unpaid Cash Capitalized as Unsecured Debt

    Unpaid cash consideration from a prior exchange agreement will be added as additional, unsecured principal to existing notes. This indicates liquidity issues and weakens the company's debt structure by adding subordinate debt.

  • Financial Distress Context

    This agreement occurs as the company faces a 'going concern' warning and is pursuing a large, speculative acquisition, underscoring its precarious financial position and the need to restructure existing obligations.


auto_awesomeAnalysis

Functional Brands Inc., a micro-cap company facing a going concern warning, has modified the terms of its Series C Convertible Preferred Stock. The conversion price was reduced to $0.1636 per share, and a prohibition on below-price conversions was waived, increasing potential dilution for common shareholders. Critically, the company is capitalizing unpaid cash consideration from a prior agreement into additional, unsecured principal on existing exchange notes, signaling significant liquidity challenges and a weakening balance sheet. This comes amidst a pending, massive acquisition, underscoring the company's precarious financial position.

At the time of this filing, MEHA was trading at $0.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $0.08 to $8.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MEHA - Latest Insights

MEHA
May 11, 2026, 5:45 PM EDT
Filing Type: 8-K
Importance Score:
8
MEHA
May 11, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
10
MEHA
May 11, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
MEHA
Apr 27, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MEHA
Apr 22, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Apr 13, 2026, 4:10 PM EDT
Filing Type: PRE 14A
Importance Score:
9
MEHA
Mar 30, 2026, 10:14 AM EDT
Filing Type: 8-K
Importance Score:
9
MEHA
Mar 27, 2026, 5:08 PM EDT
Filing Type: 10-K
Importance Score:
9
MEHA
Mar 20, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
MEHA
Mar 13, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9